Literature DB >> 33771967

E3 ubiquitin ligase Grail promotes hepatic steatosis through Sirt1 inhibition.

Pei-Yao Liu1, Cheng-Cheung Chen2, Chia-Ying Chin2,3, Te-Jung Liu4,5,6, Wen-Chiuan Tsai7,8, Jian-Liang Chou9, Chuan-Yu Huang9, Yu-Guang Chen10,11, Ying-Chuan Chen12,13.   

Abstract

In obese adults, pan class="Disease">nonalcoholic fatty liver disease (NAFLD) is accompanied by multiple metabolic dysfunctions. Although upregulated hepatic fatty acid synthesis has been identified as a crucial mediator of NAFLD development, the underlying mechanisms are yet to be elucidated. In this study, we reported upregulated expression of gene related to anergy in lymphocytes (GRAIL) in the livers of humans and mice with hepatic steatosis. Grail ablation markedly alleviated the high-fat diet-induced hepatic fat accumulation and expression of genes related to the lipid metabolism, in vitro and in vivo. Conversely, overexpression of GRAIL exacerbated lipid accumulation and enhanced the expression of lipid metabolic genes in mice and liver cells. Our results demonstrated that Grail regulated the lipid accumulation in hepatic steatosis via interaction with sirtuin 1. Thus, Grail poses as a significant molecular regulator in the development of NAFLD.

Entities:  

Year:  2021        PMID: 33771967      PMCID: PMC7997893          DOI: 10.1038/s41419-021-03608-9

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  26 in total

1.  GRAIL (gene related to anergy in lymphocytes) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3 subunit 5 and coronin 1A.

Authors:  Daiju Ichikawa; Miho Mizuno; Takashi Yamamura; Sachiko Miyake
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

2.  Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.

Authors:  Jill M Schartner; William T Simonson; Sarah A Wernimont; Lauren M Nettenstrom; Anna Huttenlocher; Christine M Seroogy
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 3.  A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators.

Authors:  Yasar Colak; Atakan Yesil; Hasan Huseyin Mutlu; Ozge Telci Caklili; Celal Ulasoglu; Ebubekir Senates; Mumtaz Takir; Osman Kostek; Yusuf Yilmaz; Feruze Yilmaz Enc; Guralp Tasan; Ilyas Tuncer
Journal:  J Gastrointestin Liver Dis       Date:  2014-09       Impact factor: 2.008

4.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages.

Authors:  Syed F Hassnain Waqas; Anh Cuong Hoang; Ya-Tin Lin; Grace Ampem; Hind Azegrouz; Lajos Balogh; Julianna Thuróczy; Jin-Chung Chen; Ivan C Gerling; Sorim Nam; Jong-Seok Lim; Juncal Martinez-Ibañez; José T Real; Stephan Paschke; Raphaëlle Quillet; Safia Ayachi; Frédéric Simonin; E Marion Schneider; Jacqueline A Brinkman; Dudley W Lamming; Christine M Seroogy; Tamás Röszer
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

6.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Authors:  Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison
Journal:  Gastroenterology       Date:  2010-09-19       Impact factor: 22.682

Review 7.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

8.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

Authors:  Aparna Purushotham; Thaddeus T Schug; Qing Xu; Sailesh Surapureddi; Xiumei Guo; Xiaoling Li
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

Review 9.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.

Authors:  Hannele Yki-Järvinen
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-07       Impact factor: 32.069

10.  The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.

Authors:  Leon L Su; Hideyuki Iwai; Jack T Lin; C Garrison Fathman
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

View more
  2 in total

1.  Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.

Authors:  Yang Liu; Yiping Li; Jue Wang; Lili Yang; Xiao Yu; Ping Huang; Haiyan Song; Peiyong Zheng
Journal:  BMC Complement Med Ther       Date:  2022-08-09

2.  HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.

Authors:  Claudia Lopez Lloreda; Sarah Chowdhury; Shivesh Ghura; Elena Alvarez-Periel; Kelly Jordan-Sciutto
Journal:  Cells       Date:  2022-09-22       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.